Last reviewed · How we verify
NCT06924983: NEMP-BGH
Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage
Phase 4 trial testing Simple neuroendoscopic hematoma evacuation in Stroke in 100 participants. Not yet recruiting.
30 November 2026
Quick facts
| Lead sponsor | Yong Jiang |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 May 2025 |
| Primary completion | 30 November 2026 |
| Estimated completion | 31 January 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Simple neuroendoscopic hematoma evacuation
- Neuroendoscopic hematoma evacuation combined with sodium methylprednisolone succinate
Conditions studied
- Stroke — all drugs for Stroke →
- Intracerebral Hemorrhage Basal Ganglia — all drugs for Intracerebral Hemorrhage Basal Ganglia →
- Methylprednisolone — all drugs for Methylprednisolone →
- Surgery — all drugs for Surgery →
Sponsor
Yong Jiang
Who can join
Adults 18 to 80, any sex, with Stroke or Intracerebral Hemorrhage Basal Ganglia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this trial is to investigate whether neuroendoscopic hematoma evacuation combined with early use of methylprednisolone sodium succinate can improve the efficacy and safety in the treatment with that of simple neuroendoscopic surgery alone for patients with spontaneous basal ganglia intracerebral hemorrhage within 24 hours after the onset.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06924983
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Simple neuroendoscopic hematoma evacuation
Trials testing the same drug.
- NCT06921616 — Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracer · Phase 4 · not yet recruiting
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Yong Jiang trials
Trials by the same sponsor.
- NCT06921616 — Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracer · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06924983 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yong Jiang
- Last refreshed: 13 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06924983.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing